Archives
-
HMGB1 and Early Diabetic Nephropathy: Proteomic Evidence
2026-10-03
Peng and colleagues used serum quantitative proteomics, Mfuzz clustering, and WGCNA to identify proteins associated with progressive diabetic nephropathy, prioritizing HMGB1 alongside four additional candidates. Their cellular and animal validation supports HMGB1 as a promising early-monitoring target, while the study remains exploratory and requires broader clinical validation before diagnostic use.
-
SLU-PP-332: ERRα/β/γ Agonist Profile
2026-10-02
SLU-PP-332 is an ERRα ERRβ ERRγ agonist that activates an exercise-associated metabolic program in preclinical models. Available evidence supports research use in mitochondrial biology and skeletal-muscle metabolism, but it does not establish human efficacy, safety, or dosage.
-
Methoxy-X04 for Reliable Amyloid Imaging
2026-10-01
Learn how Methoxy-X04 (SKU B5769) can improve amyloid imaging workflows without being mistaken for a cell-viability assay reagent. This scenario-based guide covers assay compatibility, preparation, interpretation, and practical vendor selection for Alzheimer’s disease research.
-
Capsaicin Workflows for TRPV1 and KDM1A
2026-10-01
Capsaicin supports a paired research strategy: activate TRPV1 in sensory models while testing reversible KDM1A/LSD1 inhibition in gastric cancer systems. This practical guide connects stock preparation, target-engagement assays, phenotype validation, and troubleshooting across pain, inflammation, and oncology workflows.
-
Sodium Orthovanadate in Insulin Signaling Assays
2026-09-30
Use Na3VO4 to preserve labile tyrosine phosphorylation during cell lysis, insulin-pathway immunoblotting, and protein tyrosine kinase assay development. This practical guide covers reversible inhibition, assay controls, workflow optimization, and troubleshooting for metabolic signaling experiments.
-
NLRP10 Links Keratinocyte Survival to Skin Barrier
2026-09-30
This 2024 Cell Death and Disease study identifies NLRP10 as a regulator of epidermal homeostasis in atopic dermatitis. Using human skin samples and an air-lift skin equivalent, the authors connect NLRP10 with reduced caspase-8-dependent cell death, p63 stabilization, keratinocyte differentiation, and barrier integrity.
-
Beyond Infiltration: Adrenergic Tests in Stroke Repair
2026-09-29
The post-stroke inflammatory response is increasingly understood as a tractable mechanism rather than a passive consequence of tissue injury. Building on evidence that esculetin suppresses CKLF1/CCR5-dependent neutrophil recruitment, this article outlines how ICI 118,551 hydrochloride can serve as an orthogonal β2-adrenoceptor pharmacology tool for translational researchers—while clearly separating established stroke biology from a hypothesis that still requires validation.
-
Caspase-3 Colorimetric Assay Kit Guide
2026-09-29
The Caspase-3 Colorimetric Assay Kit provides a lysate-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is appropriate for relative caspase activity measurement in apoptosis and neurodegeneration studies, but not for in vivo imaging, tissue staining, diagnosis, or pathway-specific conclusions from absorbance alone.
-
IgSF6, ER Stress, and Antibacterial Macrophages
2026-09-28
The reference study identifies IgSF6 as an endoplasmic-reticulum-localized immunoglobulin superfamily protein that restrains stress and inflammatory signaling in intestinal macrophages. Its loss improves resistance to Salmonella Typhimurium but worsens chemically induced colitis, revealing a context-dependent tradeoff between antibacterial activity and intestinal homeostasis.
-
Atorvastatin Assay Design: From Viability to Mechanism
2026-09-28
A practical guide to using Atorvastatin (SKU C6405) in viability and proliferation assays, from solvent controls and dose selection to interpretation of vascular and cancer-model findings. It distinguishes product-dossier benchmarks from workflow recommendations and links to the supporting product information and ferroptosis study.
-
Flavopiridol: CDK Biology Meets Intestinal ER Stress
2026-09-27
Explore how Flavopiridol (L868275) can help probe CDK-dependent biology without confusing kinase inhibition with a direct ER-stress model. This article unpacks intestinal stem-cell findings and translates them into cautious, practical assay decisions.
-
NLRP10 Links Keratinocyte Survival to AD Barrier Function
2026-09-26
The 2024 study identifies NLRP10 as a regulator of epidermal homeostasis, connecting reduced expression in atopic dermatitis (AD) with caspase-8-mediated keratinocyte death and impaired p63-dependent differentiation. Its human skin equivalent model provides a framework for investigating how cell survival and differentiation jointly shape epidermal barrier function, while the proposed mechanisms remain to be tested across additional models and patient groups.
-
Methoxy-X04 in rTMS Alzheimer’s Research
2026-09-25
Methoxy-X04 is a fluorescent amyloid beta probe that can connect plaque imaging with emerging research on neural circuit–microglia signaling. This article explains how to interpret its signal alongside findings on rTMS, the Cx3cl1-Cx3cr1 axis, and amyloid clearance.
-
Erastin B1524: Practical Ferroptosis Assays
2026-09-25
A scenario-driven guide to using Erastin (SKU B1524) in ferroptosis research, from model selection and solution preparation to interpreting viability and ROS results. It separates product-supported parameters from practical recommendations and explains why oxidative stress alone does not confirm ferroptosis.
-
Erastin Workflows for Ferroptosis Research
2026-09-24
Use Erastin to probe system Xc⁻-linked redox vulnerability in tumor-cell models, with a practical workflow for dosing, readouts, and troubleshooting. A recent targeted-nanoparticle study adds useful assay ideas for tracking lipid oxidation and mitochondrial injury—without implying that its platform and Erastin are interchangeable.